Cover Image

Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats

Cannabidiol (CBD) is a non-psychotomimetic compound from Cannabis sativa that presents antipsychotic, anxiolytic, anti-inflammatory and neuroprotective effects. In Parkinson's disease patients, CBD is able to attenuate the psychotic symptoms induced by L-DOPA and to improve quality of life. Rep...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fernanda Fiel Peres (Author), Raquel Levin (Author), Mayra Akimi Suiama (Author), Mariana Cepollaro Diana (Author), Douglas Albuquerque Gouvêa (Author), Valéria Almeida (Author), Camila Maurício Santos (Author), Lisandro Lungato (Author), Antonio Waldo Zuardi (Author), Jaime Eduardo Hallak (Author), José Alexandre Crippa (Author), Vânia D'Almeida (Author), Regina H Silva (Author), Vanessa Costhek Abilio (Author)
Format:	Book
Published:	Frontiers Media S.A., 2016-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy
by: Fernanda Fiel Peres, et al.
Published: (2016)

Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
by: Cássio Morais Loss, et al.
Published: (2021)

Effects of Cannabinoid Drugs on the Deficit of Prepulse Inhibition of Startle in an Animal Model of Schizophrenia: the SHR Strain
by: Raquel eLevin, et al.
Published: (2014)

Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
by: Fernanda F. Peres, et al.
Published: (2018)

∆9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
by: José Alexandre Crippa, et al.
Published: (2016)

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
by: Fernanda F. Peres, et al.
Published: (2018)

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
by: Francieli Vuolo, et al.
Published: (2015)

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
by: Antonio W. Zuardi, et al.
Published: (2017)

No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
by: Ila M. P. Linares, et al.
Published: (2018)

Is the so contemned reserpine back?
by: David García Barreto, et al.
Published: (2014)

Therapeutic potential of Reserpine in metabolic syndrome
by: Udaya Pratap Singh, et al.
Published: (2023)

Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations
by: José Diogo S. Souza, et al.
Published: (2022)

Systemic Chronic Treatment with Cannabidiol in Carioca High- and Low-Conditioned Freezing Rats in the Neuropathic Pain Model: Evaluation of Pain Sensitivity
by: Carolina Macêdo-Souza, et al.
Published: (2023)

Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats
by: Karina Genaro, et al.
Published: (2017)

Effect of daidzein on Parkinson disease induced by reserpine in rats
by: Radha Goel, et al.
Published: (2020)

Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020-2022)
by: José Diogo R. Souza, et al.
Published: (2022)

Therapeutic potential of reserpine in metabolic syndrome: An evidence-based study
by: Kanika Verma, et al.
Published: (2023)

¿Regresa la Tan vilipendiada reserpina?. Is the so contemned reserpine back?
by: David García Barreto, et al.
Published: (1998)

Population Pharmacokinetic-Pharmacodynamic Analysis of a Reserpine-Induced Myalgia Model in Rats
by: Gloria M. Alfosea-Cuadrado, et al.
Published: (2024)

Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic
by: José Diogo S. Souza, et al.
Published: (2022)

Expectativa de desempenho social de pacientes psiquiátricos internados em hospital geral
by: Maria Stela Setti Moreira, et al.

Expectativa de desempenho social de pacientes psiquiátricos internados em hospital geral
by: Maria Stela Setti Moreira, et al.
Published: (2002)

Expectativa de desempenho social de pacientes psiquiátricos internados em hospital geral Social performance expectations in psychiatric patients of a general hospital ward
by: Maria Stela Setti Moreira, et al.
Published: (2002)

Expectativa de desempenho social de pacientes psiquiátricos internados em hospital geral
by: Moreira Maria Stela Setti, et al.
Published: (2002)

Evaluation of the therapeutic effect of mesoporous silica nanoparticles loaded with Gallic acid on reserpine-induced depression in Wistar rats
by: Heba M. Fahmy, et al.
Published: (2022)

A Multicenter Retrospective Analysis on Clinical Effectiveness and Economic Assessment of Compound Reserpine and Hydrochlorothiazide Tablets (CRH) for Hypertension
by: Li S, et al.
Published: (2020)

Si-Ni-San Prevents Reserpine-Induced Depression by Inhibiting Inflammation and Regulating CYP450 Enzymatic Activity
by: Yang Zong, et al.
Published: (2020)

Cure-All cannabidiol? The cannabidiol content of commercial products
by: Michaela Mouton, et al.
Published: (2024)

Integrating Pharmacology and Gut Microbiota Analysis to Explore the Mechanism of Citri Reticulatae Pericarpium Against Reserpine-Induced Spleen Deficiency in Rats
by: Yuying Zheng, et al.
Published: (2020)

Zingiber officinale Ethanolic Extract Attenuated Reserpine-Induced Depression-Like Condition and Associated Hippocampal Aberrations in Experimental Wistar Rats
by: Olanrewaju JA, et al.
Published: (2020)

Preclinical reserpine models recapitulating motor and non-motor features of Parkinson's disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairment
by: Yang Li, et al.
Published: (2022)

Synthesis and DPPH scavenging assay of reserpine analogues, computational studies and in silico docking studies in AChE and BChE responsible for Alzheimer's disease
by: Muhammad Yar, et al.
Published: (2015)

Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users
by: Davide Fortin, et al.
Published: (2021)

Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges
by: Miguel Olivas-Aguirre, et al.
Published: (2022)

Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature
by: Crippa José AS, et al.
Published: (2012)

Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
by: Franciele F. Scarante, et al.
Published: (2021)

The Perspective of Cannabidiol in Psoriasis Therapy
by: Stanescu AMA, et al.
Published: (2024)

The therapeutic potential of purified cannabidiol
by: Saoirse Elizabeth O'Sullivan, et al.
Published: (2023)

Acceptability of cannabidiol in patients with psychosis
by: Edward Chesney, et al.
Published: (2022)

Pharmacovigilance on cannabidiol as an antiepileptic agent
by: Ilaria Ammendolia, et al.
Published: (2023)